Your browser doesn't support javascript.
loading
TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
Sengupta, Srona; Board, Nathan L; Wu, Fengting; Moskovljevic, Milica; Douglass, Jacqueline; Zhang, Josephine; Reinhold, Bruce R; Duke-Cohan, Jonathan; Yu, Jeanna; Reed, Madison C; Tabdili, Yasmine; Azurmendi, Aitana; Fray, Emily J; Zhang, Hao; Hsiue, Emily Han-Chung; Jenike, Katharine; Ho, Ya-Chi; Gabelli, Sandra B; Kinzler, Kenneth W; Vogelstein, Bert; Zhou, Shibin; Siliciano, Janet D; Sadegh-Nasseri, Scheherazade; Reinherz, Ellis L; Siliciano, Robert F.
Afiliação
  • Sengupta S; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Board NL; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Wu F; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Moskovljevic M; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Douglass J; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Zhang J; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
  • Reinhold BR; Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
  • Duke-Cohan J; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Yu J; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
  • Reed MC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
  • Tabdili Y; Department of Medicine, Harvard Medical School, Boston, MA 02115.
  • Azurmendi A; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
  • Fray EJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
  • Zhang H; Department of Medicine, Harvard Medical School, Boston, MA 02115.
  • Hsiue EH; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Jenike K; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Ho YC; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Gabelli SB; Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
  • Kinzler KW; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Vogelstein B; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
  • Zhou S; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
  • Siliciano JD; Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
  • Sadegh-Nasseri S; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Reinherz EL; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06519.
  • Siliciano RF; Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Proc Natl Acad Sci U S A ; 119(15): e2123406119, 2022 04 12.
Article em En | MEDLINE | ID: mdl-35394875
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV / Anticorpos Biespecíficos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV / Anticorpos Biespecíficos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article